Inotiv, inc. expands safety pharmacology offering to include cardiopulmonary telemetry

West lafayette, ind., may 04, 2023 (globe newswire) -- inotiv, inc. (nasdaq: notv), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, and research models and related products and services, announced today the expansion of the company's safety pharmacology offering with the validation and verification of a cardiopulmonary telemetry study model in cynomolgus macaques. offered through inotiv's discovery and safety assessment business, telemetry allows for the continuous observation of ecg, respiratory rate and volume, blood pressure and other cardiovascular parameters during preclinical safety studies.
NOTV Ratings Summary
NOTV Quant Ranking